Quick Answer
IO Biotech, Inc. reported Total Assets of $67.70 million for fiscal year 2024.
IO Biotech, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $67.70M | -55.1% |
| 2023 | $150.72M | -0.7% |
| 2022 | $151.81M | -31.7% |
| 2021 | $222.29M | +3832.2% |
| 2020 | $5.65M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $39.96M | -55.6% | -5.6% |
| June 30, 2025 | $42.33M | -62.0% | -7.5% |
| March 31, 2025 | $45.74M | -64.3% | -32.4% |
| December 31, 2024 | $67.70M | -55.1% | -24.7% |
| September 30, 2024 | $89.94M | -47.9% | -19.3% |
| June 30, 2024 | $111.47M | -5.2% | -13.0% |
| March 31, 2024 | $128.16M | -6.3% | -15.0% |
| December 31, 2023 | $150.72M | -0.7% | -12.7% |
- IO Biotech, Inc. showed a decrease of -55.1% in Total Assets compared to the prior fiscal year.
- Over the 2020–2024 period, IO Biotech, Inc.’s total assets has grown by 1097.6% (from $5.65 million to $67.70 million).
- The most recent figure is from IO Biotech, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: